Martín E. Fernández-Zapico

17.8k total citations · 1 hit paper
172 papers, 7.7k citations indexed

About

Martín E. Fernández-Zapico is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Martín E. Fernández-Zapico has authored 172 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Molecular Biology, 64 papers in Oncology and 27 papers in Surgery. Recurrent topics in Martín E. Fernández-Zapico's work include Hedgehog Signaling Pathway Studies (41 papers), Pancreatic and Hepatic Oncology Research (39 papers) and Epigenetics and DNA Methylation (30 papers). Martín E. Fernández-Zapico is often cited by papers focused on Hedgehog Signaling Pathway Studies (41 papers), Pancreatic and Hepatic Oncology Research (39 papers) and Epigenetics and DNA Methylation (30 papers). Martín E. Fernández-Zapico collaborates with scholars based in United States, Germany and France. Martín E. Fernández-Zapico's co-authors include Raúl Urrutia, Daniel D. Billadeau, Maite G. Fernández‐Barrena, Andrei V. Ougolkov, Kenneth P. Olive, Luciana L. Almada, Carmine F. Palermo, Stephen A. Sastra, Jan Kitajewski and Andrew D. Rhim and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Martín E. Fernández-Zapico

165 papers receiving 7.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

2014 1.5k citations Carmine F. Palermo, Stephen A. Sastra et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martín E. Fernández-Zapico United States	47	5.0k	3.0k	1.5k	1.2k	854	172	7.7k
Tan A. Ince United States	42	6.2k 1.2×	2.3k 0.8×	1.3k 0.8×	726 0.6×	904 1.1×	73	9.1k
Sandy Chang United States	46	7.6k 1.5×	3.2k 1.1×	1.4k 0.9×	888 0.8×	628 0.7×	88	11.3k
James W. Horner United States	33	6.5k 1.3×	3.1k 1.0×	1.3k 0.9×	1.3k 1.1×	704 0.8×	42	10.0k
Manuel Collado Spain	34	5.8k 1.2×	2.4k 0.8×	1.4k 0.9×	1.5k 1.3×	509 0.6×	78	9.2k
Morgan Truitt United States	19	3.1k 0.6×	2.7k 0.9×	1.4k 0.9×	1.4k 1.2×	496 0.6×	27	6.0k
Jan Köster Netherlands	46	5.6k 1.1×	2.2k 0.7×	1.8k 1.2×	687 0.6×	649 0.8×	190	8.5k
Rachel A. Ridgway United Kingdom	29	3.5k 0.7×	2.5k 0.8×	1.2k 0.8×	518 0.4×	1.2k 1.4×	45	6.3k
Monica Nistér Sweden	50	5.5k 1.1×	2.4k 0.8×	1.9k 1.2×	789 0.7×	447 0.5×	160	9.1k
Atsushi Iwama Japan	64	7.6k 1.5×	2.2k 0.7×	1.5k 1.0×	2.5k 2.2×	631 0.7×	251	12.1k
Robert G. Ramsay Australia	50	3.6k 0.7×	2.1k 0.7×	939 0.6×	934 0.8×	1.0k 1.2×	176	6.5k

Countries citing papers authored by Martín E. Fernández-Zapico

Since Specialization

Citations

This map shows the geographic impact of Martín E. Fernández-Zapico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martín E. Fernández-Zapico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martín E. Fernández-Zapico more than expected).

Fields of papers citing papers by Martín E. Fernández-Zapico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martín E. Fernández-Zapico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martín E. Fernández-Zapico. The network helps show where Martín E. Fernández-Zapico may publish in the future.

Co-authorship network of co-authors of Martín E. Fernández-Zapico

This figure shows the co-authorship network connecting the top 25 collaborators of Martín E. Fernández-Zapico. A scholar is included among the top collaborators of Martín E. Fernández-Zapico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martín E. Fernández-Zapico. Martín E. Fernández-Zapico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vinaixa, Judith, Neus Martínez‐Bosch, Patricia Santofimia‐Castaño, et al.. (2025). Nuclear Galectin-1 promotes KRAS -dependent activation of pancreatic cancer stellate cells. Proceedings of the National Academy of Sciences. 122(14). e2424051122–e2424051122. 2 indexed citations

Jazieh, Khalid, et al.. (2025). Identification of Candidate Alterations Mediating KRAS G12C Inhibitor Resistance in Advanced Colorectal and Pancreatic Cancers. Clinical Cancer Research. 31(5). 899–906. 6 indexed citations

Johnson, Katherine M., Eugene W. Krueger, Carrie J. Heppelmann, et al.. (2023). Ectopic expression of DOCK8 regulates lysosome-mediated pancreatic tumor cell invasion. Cell Reports. 42(9). 113042–113042. 1 indexed citations

Decker-Farrell, Amanda R., Lukas Vlahos, H. Carlo Maurer, et al.. (2023). Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Cancer Discovery. 14(2). 348–361. 11 indexed citations

Tella, Sri Harsha, Nathan R. Foster, Qian Shi, et al.. (2023). Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma. The Oncologist. 28(10). 917–e966. 1 indexed citations

Binder, Moritz, Ryan M. Carr, Terra L. Lasho, et al.. (2022). Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia. Nature Communications. 13(1). 1434–1434. 14 indexed citations

Dasgupta, Aneesha, R. Schmitt, Dong Seong Cho, et al.. (2021). Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer. JCI Insight. 7(2). 14 indexed citations

McCleary‐Wheeler, Angela L., Brooke D. Paradise, Luciana L. Almada, et al.. (2020). TFII-I-mediated polymerase pausing antagonizes GLI2 induction by TGFβ. Nucleic Acids Research. 48(13). 7169–7181. 7 indexed citations

Pietrobono, Silvia, Fabrizio Manetti, Luciana L. Almada, et al.. (2020). ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL. Nature Communications. 11(1). 5865–5865. 66 indexed citations

10.

Ha, Yeonjung, Yong Fang, Paola Romecín, et al.. (2019). Induction of Lysosome‐associated Protein Transmembrane 4 Beta via Sulfatase 2 Enhances Autophagic Flux in Liver Cancer Cells. Hepatology Communications. 3(11). 1520–1543. 4 indexed citations

11.

Liu, Mingyang, Yu‐Qing Zhang, Jingxuan Yang, et al.. (2019). ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. Gastroenterology. 158(3). 679–692.e1. 109 indexed citations

12.

Rajurkar, Mihir, Kyvan Dang, Maite G. Fernández‐Barrena, et al.. (2017). IKBKE Is Required during KRAS-Induced Pancreatic Tumorigenesis. Cancer Research. 77(2). 320–329. 33 indexed citations

13.

Lamberti, María Julia, et al.. (2017). Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy. PLoS ONE. 12(5). e0177801–e0177801. 48 indexed citations

14.

Razidlo, Gina L., Arthur C. Sletten, Rachel M. Hurley, et al.. (2015). Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion. Cancer Research. 75(14). 2907–2915. 36 indexed citations

15.

Bednar, Filip, Heather Schofield, Meredith A. Collins, et al.. (2015). Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. Carcinogenesis. 36(7). 730–738. 21 indexed citations

16.

Martínez‐Bosch, Neus, Maite G. Fernández‐Barrena, Mireia Moreno, et al.. (2014). Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation. Cancer Research. 74(13). 3512–3524. 93 indexed citations

17.

Joost, Simon, Luciana L. Almada, Anne M. Vrabel, et al.. (2011). GLI1 Inhibition Promotes Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells. Cancer Research. 72(1). 88–99. 54 indexed citations

18.

Ye, Hong, et al.. (2011). Sequential Activation of Snail1 and N-Myc Modulates Sonic Hedgehog–Induced Transformation of Neural Cells. Cancer Research. 71(15). 5336–5345. 19 indexed citations

19.

Ilyas, Sumera I., Cathrine J. DeMars, Andrea Comba, et al.. (2010). Combinatorial Chemoprevention Reveals a Novel Smoothened-Independent Role of GLI1 in Esophageal Carcinogenesis. Cancer Research. 70(17). 6787–6796. 38 indexed citations

20.

Ougolkov, Andrei V., Martín E. Fernández-Zapico, Doris N. Savoy, Raúl Urrutia, & Daniel D. Billadeau. (2005). Glycogen Synthase Kinase-3β Participates in Nuclear Factor κB–Mediated Gene Transcription and Cell Survival in Pancreatic Cancer Cells. Cancer Research. 65(6). 2076–2081. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact